GlobalSpace Technologies is currently trading at Rs. 85.00, up by 8.75 points or 11.48% from its previous closing of Rs. 76.25 on the BSE.
The scrip opened at Rs. 77.85 and has touched a high and low of Rs. 80.00 and Rs. 75.00 respectively. So far 24269 shares were traded on the counter.
The BSE group ‘B’ stock of face value Rs. 10 has touched a 52 week high of Rs. 89.65 on 30-Jun-2020 and a 52 week low of Rs. 44.00 on 16-Apr-2020.
Last one week high and low of the scrip stood at Rs. 87.50 and Rs. 73.50 respectively. The current market cap of the company is Rs. 90.74 crore.
The promoters holding in the company stood at 55.30%, while Non-Institutions held 44.70%.
GlobalSpace Technologies has declared formal launch and endorsement for DocExa platform from FOGSI (Federation of Obstetric and Gynaecological Societies of India) for providing mobile and web-based application to its member Doctors to setup their virtual clinic. FOGSI is recommending DocExa as a virtual partner and it is been formerly launched with its associate members.
After the major tie-ups with two Marquee logo companies – Cadila Pharma and Macleods Pharma, this is the major breakthrough for the Company. This further enhances faith on Company’s capability to take the product on a larger platform. GlobalSpace has developed the first Artificial Intelligence (AI) enabled virtual consultation app – DocExa.
GlobalSpace Technologies is a Digital, Mobility, Analytics, AI & Cloud technology company providing integrated healthtech platforms to major stakeholders of Healthcare domain.
